[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Theravance Bio Ord (TBPH)

Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Theravance Bio Ord 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 USA

www.theravance.com Employees: 90 P: 650-808-6000

Sector:

Medical

Description:

Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.'

Key Statistics

Overview:

Market Capitalization, $K 853,202
Enterprise Value, $K 685,392
Shares Outstanding, K 51,553
Float, K 47,609
% Float 92.35%
Short Interest, K 5,160
Short Float 10.01%
Days to Cover 14.10
Short Volume Ratio 0.62
% of Insider Shareholders 7.65%
% of Institutional Shareholders 99.10%

Financials:

Annual Sales, $ 107,460 K
Annual Net Income, $ 105,900 K
Last Quarter Sales, $ 17,700 K
Last Quarter Net Income, $ -4,930 K
EBIT, $ 1,340 K
EBITDA, $ 140 K

Growth:

1-Year Return 73.65%
3-Year Return 47.74%
5-Year Return -5.44%
5-Year Revenue Growth 49.54%
5-Year Earnings Growth 88.10%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.01 on 05/07/26
Next Earnings Date 08/11/26
Earnings Per Share ttm 0.96
EPS Growth vs. Prev Qtr -100.00%
EPS Growth vs. Prev Year 77.78%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TBPH Ratios

Ratio
Price/Earnings ttm 16.93
Price/Earnings forward 17.10
Price/Earnings to Growth N/A
Return-on-Equity % 18.84%
Return-on-Assets % 10.94%
Profit Margin % 98.55%
Debt/Equity 0.00
Price/Sales 7.80
Price/Cash Flow N/A
Price/Book 2.88
Book Value/Share 5.64
Interest Coverage 53.54
60-Month Beta 0.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.